Genocea Biosciences Publishes Preclinical Data for Investigational Vaccine Candidate for HSV-2
3/18/2013 9:59:42 AM
More...
|
Industry Veteran Katrine Bosley Joins Genocea Biosciences' Board of Directors
3/12/2013 6:53:12 AM
More...
|
Genocea Biosciences Lands $30 Million Series C
10/10/2012 6:46:44 AM
More...
|
Genocea Biosciences Initiates a Phase 1/2a Study With Its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)
8/15/2012 10:06:54 AM
More...
|
Genocea Biosciences Unveils Protective Therapeutic Vaccine for Herpes Simplex Virus Type 2 (HSV-2)
8/6/2012 9:25:05 AM
More...
|
Genocea Biosciences Announces New Research Identifying Potential Vaccine Candidates for Chlamydia
6/7/2012 9:56:18 AM
More...
|
Genocea Biosciences Highlights Key Progress in the Development of its First Vaccine Candidate, Targeting HSV-2
5/4/2012 10:17:19 AM
More...
|
Genocea Biosciences Release: Novel T Cell Antigen Discovery Platform Providing New Momentum on Malaria Vaccine
4/11/2012 10:20:51 AM
More...
|
Genocea Biosciences to Present at the 8th International Symposium on Pneumococci and Pneumococcal Diseases
3/12/2012 7:47:36 AM
More...
|
Genocea Biosciences to Present at Biotech Showcase(TM) 2012
1/3/2012 6:30:56 AM
More...
|
|